van Doorninck, John A <br/><br/>
Current treatment protocols have eliminated the prognostic advantage of type 1 fusions in Ewing sarcoma: a report from the Children's Oncology Group.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Apr 2010 
 - 1989-94 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1527-7755 
<br/><br/><label>Standard No.: </label>10.1200/JCO.2009.24.5845  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Biopsy<br/>Bone Neoplasms--genetics<br/>Chi-Square Distribution<br/>Child<br/>Child, Preschool<br/>Disease-Free Survival<br/>Female<br/>Gene Expression Regulation, Neoplastic<br/>Genetic Predisposition to Disease<br/>Humans<br/>Infant<br/>Kaplan-Meier Estimate<br/>Logistic Models<br/>Male<br/>Oncogene Proteins, Fusion--genetics<br/>Phenotype<br/>Prospective Studies<br/>Proto-Oncogene Protein c-fli-1--genetics<br/>RNA-Binding Protein EWS<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Risk Assessment<br/>Risk Factors<br/>Sarcoma, Ewing--genetics<br/>Time Factors<br/>Transcription Factors--genetics<br/>Treatment Outcome<br/>United States<br/>Young Adult